UK: Oxford vaccine found 90% effective in clinical testing

The Oxford vaccine has yielded very good results. The vaccine developed by the University of Oxford was 90% effective in preventing COVID-19 when it was administered as a half-dose
after a full dose after at least one month, according to late-stage trials in the UK.

The Serum Institute of India, the largest producer of vaccines in the world, has partnered with AstraZeneca